Atlas Trials

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Clinical trial NCT04060459 · UNKNOWN

Trial details

NCT number
NCT04060459
Sponsor
Third Military Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2018-10-01
Primary completion
2020-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.